5-苯氧基-o-茴香胺 | 116289-67-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-苯氧基-o-茴香胺
• 中文别名: 5-苯氧基邻甲氧基苯胺
• 英文名称: 2-methoxy-5-phenoxy-aniline
• 英文别名: 2-Methoxy-5-phenoxy-anilin；5-phenoxy-o-anisidine；2-Methoxy-5-phenoxyaniline
• CAS: 116289-67-9
• 化学式: C₁₃H₁₃NO₂
• mdl: MFCD00270120
• 分子量: 215.252
• InChiKey: SCDKUQBOSDILAR-UHFFFAOYSA-N

物化性质

• 熔点：
  68-70°C
• 沸点：
  343.9±27.0 °C(Predicted)
• 密度：
  1.155±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 安全说明：
  S26
• 危险类别码：
  R36/37/38
• 海关编码：
  2922299090

反应信息

• 作为反应物：
  描述：

  5-苯氧基-o-茴香胺 在 硫酸 、 potassium iodide 作用下， 生成 2-iodo-1-methoxy-4-phenoxy-benzene
  参考文献：
  名称：

  Iodo Derivatives of Phenyl Ether. II. Studies in Orientation

  摘要：

  DOI：

  10.1021/ja01265a038
• 作为产物：
  描述：

  1-甲氧基-2-硝基-4-苯氧基-苯 在 铂 作用下， 生成 5-苯氧基-o-茴香胺
  参考文献：
  名称：

  Iodo Derivatives of Phenyl Ether. II. Studies in Orientation

  摘要：

  DOI：

  10.1021/ja01265a038

文献信息

• Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof
  申请人：Cytovia, Inc.

  公开号：US20030069239A1

  公开（公告）日：2003-04-10

  The present invention is directed to substituted 2-aryl-4-arylaminopyrimidine and analogs thereof, represented by the general Formula I: 1 wherein A, Ar 1 , Ar 2 , R 1 and R 3 are defined herein. The present invention also relates to the discovery that compounds having Formula I are activators of caspases and inducers of apoptosis. The compounds of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  本发明涉及被一般式I所代表的取代的2-芳基-4-芳基氨基嘧啶及其类似物： 其中A，Ar1，Ar2，R1和R3在此处被定义。本发明还涉及发现具有式I的化合物是caspase的激活剂和凋亡诱导剂。本发明的化合物可用于诱导在出现未受控制的异常细胞生长和扩散的各种临床病况中的细胞死亡。
• Benzothiazole derivatives with activity as adenosine receptor ligands
  申请人：——

  公开号：US20020045615A1

  公开（公告）日：2002-04-18

  The present invention relates to substituted benzothiazole derivitives and to their pharmaceutically acceptable salts useful for the treatment of diseases related to the adenosine receptor.

  本发明涉及替代苯并噻唑衍生物及其药用可接受的盐，用于治疗与腺苷受体相关的疾病。
• Regioselective Friedel−Crafts Alkylation of Anilines and Amino-Substituted Heteroarenes with Hexafluoroacetone Sesquihydrate
  作者：Raffaello Masciadri、Matthias Kamer、Nadine Nock

  DOI：10.1002/ejoc.200300501

  日期：2003.11

  aminopyridines, underwent regioselective Friedel−Crafts alkylation in neat hexafluoroacetone sesquihydrate in a broad range of temperatures, reaction times, and yields (2%−94%) depending strongly on the electron density of the substrate. Prior N,N-dibenzylation of aniline and 2-aminopyridine strongly promoted substrate reactivity and resulted in higher yields (> 80%). The described Friedel−Crafts alkylations in

  各种芳烃，包括苯胺、吡咯、吲哚、氨基恶唑、氨基噻唑、氨基喹啉和氨基吡啶，在纯六氟丙酮倍半水合物中在广泛的温度、反应时间和产率 (2%−94%) 中进行区域选择性 Friedel-Crafts 烷基化很大程度上取决于基板的电子密度。苯胺和 2-氨基吡啶的先前 N,N-二苄基化强烈促进底物反应性并导致更高的产率 (> 80%)。六氟丙酮倍半水合物中所描述的 Friedel-Crafts 烷基化发生在苯胺的对位或杂芳烃中 sp2 杂化氮原子的 β 位置。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)
• N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
  申请人：Cai Xiong Sui

  公开号：US20070099877A1

  公开（公告）日：2007-05-03

  Disclosed are N-aryl-thienopyrimidin-4-amines and analogs thereof, represented by the Formulae I-II: wherein Ar and R 1 -R 4 are defined herein. The present invention relates to the discovery that compounds having Formulae I-II are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  揭示了N-芳基噻吩吡嘧啶-4-胺及其类似物，由以下的式子I-II表示：其中Ar和R1-R4在此有所定义。本发明涉及发现具有式子I-II的化合物是半胱氨酸蛋白酶的激活剂和凋亡诱导剂。因此，本发明的半胱氨酸蛋白酶激活剂和凋亡诱导剂可用于诱导在各种临床病况中发生细胞死亡，这些病况中存在细胞不受控制的生长和异常细胞的扩散。
• Nf-kb activation inhibitors
  申请人：Muto Susumu

  公开号：US20060089395A1

  公开（公告）日：2006-04-27

  A medicament having inhibitory activity against NF-κB activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein A represents hydrogen atom or acetyl group, E represents a 2,5-di-substituted or a 3,5-di-substituted phenyl group, or a monocyclic or a fused polycyclic heteroaryl group which may be substituted, provided that the compound wherein said heteroaryl group is circle around (1)} a fused polycyclic heteroaryl group wherein the ring which binds directly to —CONH— group in the formula (I) is a benzene ring, circle around (2)} unsubstituted thiazol-2-yl group, or circle around (3)} unsubstituted benzothiazol-2-yl group is excluded, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —CONH-E wherein E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —CONH-E wherein E has the same meaning as that defined above.

  一种药物具有抑制NF-κB活化作用，其包括以下通式(I)所表示的化合物或其药学上可接受的盐、水合物和溶剂化物作为活性成分，其中A代表氢原子或乙酰基，E代表2,5-二取代或3,5-二取代苯基或单环或融合的多环杂环芳基，其可以被取代，但在所述杂环芳基是圆圈(1)}在公式(I)中直接结合—CONH—基团的环为苯环的融合多环杂环芳基，圆圈(2)}未取代的噻唑-2-基团，或者圆圈(3)}未取代的苯并噻唑-2-基团时，不包括该化合物，环Z代表一个芳香烃，除了由公式—O-A所表示的基团外，它也可以有一个或多个取代基，其中A具有与上述定义相同的含义，公式—CONH-E所表示的基团E具有与上述定义相同的含义。